Topics
Glioblastoma | Treatment | Integrative medicine | Circadian clock
Home > Publications > Topics > Glioblastoma > Treatment > Integrative medicine > Circadian clock
Chan P, Nagai Y, Wu Q, Hovsepyan A, Mkhitaryan S, Wang J,
Karapetyan G, Kamenecka T, Solt LA, Cope J, Moats RA, Hirota T,
Rich JN, Kay SA.
Advancing Clinical
Response Against Glioblastoma: Evaluating SHP1705 CRY2 Activator
Efficacy in Preclinical Models and Safety in Phase I Trials.
bioRxiv [Preprint]. 2024 Sep 21:2024.09.17.613520.
doi:
10.1101/2024.09.17.613520. PMID:
39345648. Interventional study. ˍ
Zhang Y, Zhang Q, Liu R, Zhang D, Hu G, Chen X.
Circadian
disruption in cancer
and regulation of cancer stem cells by circadian clock genes: An
updated review.
Cancer
Lett. 2024 Dec 11:217391. doi:
10.1016/j.canlet.2024.217391. PMID:
39672457. Review. ˍ